Universitaire Ziekenhuizen Leuven

Running trials

• Recruiting

  A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  NCT07008118· Phase 1· Source

• Active, not recruiting

  Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

  NCT06747572· Source

• Enrolling by invitation

  Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

  NCT06066580· Phase 2· Source

• Recruiting

  Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC

  NCT04688528· Source

• Recruiting

  A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  NCT04710576· Phase 2· Source

• Active, not recruiting

  The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries

  NCT04192747· Source

• Active, not recruiting

  A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT04557098· Phase 2· Source

• Active, not recruiting

  The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial

  NCT03447938· Source

• Active, not recruiting

  Anatomical Shoulder Domelock System Study

  NCT03312465· Source

• Active, not recruiting

  Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

  NCT03049189· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Duchenne muscular dystrophy1 recruiting
• Head and neck cancer1 recruiting
• Myeloproliferative neoplasms1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

  NCT05923827· Source

• Completed

  A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter

  NCT05828173· Source

• Completed

  Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

  NCT05291091· Phase 2· Source

• Completed

  Maternal Treatment With ACE-inhibitors and Breastfeeding: a Mono-centric Study on the Exposure Through Breast Milk

  NCT06088849· Source

• Completed

  MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)

  NCT04509791· Phase 2· Source

• Completed

  PREMOM-II: Pregnancy Remote Monitoring of Women with Gestational Hypertensive Disorders

  NCT04031430· Source

• Recruiting

  Cardiopulmonary Toxicity of Thoracic Radiotherapy

  NCT03978377· Source

• Completed

  Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma

  NCT03361748· Phase 2· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Source